Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Fouquet G, Marcq I, Debuysscher V, Bayry J, Rabbind Singh A, Bengrine A, Nguyen-Khac E, Naassila M, Bouhlal H.

Oncotarget. 2018 Feb 26;9(22):16248-16262. doi: 10.18632/oncotarget.24575. eCollection 2018 Mar 23. Review.

2.

Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugs.

Fouquet G, Debuysscher V, Ouled-Haddou H, Eugenio MS, Demey B, Singh AR, Ossart C, Al Bagami M, Regimbeau JM, Nguyen-Khac E, Naassila M, Marcq I, Bouhlal H.

Oncotarget. 2016 May 31;7(22):32493-503. doi: 10.18632/oncotarget.8679.

3.

RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation.

Bouhlal H, Ouled-Haddou H, Debuysscher V, Singh AR, Ossart C, Reignier A, Hocini H, Fouquet G, Al Baghami M, Eugenio MS, Nguyen-Khac E, Regimbeau JM, Marcq I.

Oncotarget. 2016 Mar 1;7(9):9832-43. doi: 10.18632/oncotarget.6954.

4.

Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.

LeGoff J, Roques P, Jenabian MA, Charpentier C, Brochier C, Bouhlal H, Gresenguet G, Frost E, Pepin J, Mayaud P, Belec L; ANRS12-12 Study Group.

Clin Microbiol Infect. 2015 Sep;21(9):873.e1-9. doi: 10.1016/j.cmi.2015.05.014. Epub 2015 May 21.

5.

The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells.

Louandre C, Marcq I, Bouhlal H, Lachaier E, Godin C, Saidak Z, François C, Chatelain D, Debuysscher V, Barbare JC, Chauffert B, Galmiche A.

Cancer Lett. 2015 Jan 28;356(2 Pt B):971-7. doi: 10.1016/j.canlet.2014.11.014. Epub 2014 Nov 12.

PMID:
25444922
6.

The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infection.

Cartier F, Marcq I, Douam F, Ossart C, Regnier A, Debuysscher V, Lavillette D, Bouhlal H.

PLoS One. 2014 Jun 13;9(6):e99601. doi: 10.1371/journal.pone.0099601. eCollection 2014.

7.

Natural autoantibodies to Fcγ receptors in intravenous immunoglobulins.

Bouhlal H, Martinvalet D, Teillaud JL, Fridman C, Kazatchkine MD, Bayry J, Lacroix-Desmazes S, Kaveri SV.

J Clin Immunol. 2014 Jul;34 Suppl 1:S4-11. doi: 10.1007/s10875-014-0019-2. Epub 2014 Apr 1.

PMID:
24682714
8.

Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.

Marcq I, Nyga R, Cartier F, Amrathlal RS, Ossart C, Ouled-Haddou H, Ghamlouch H, Galmiche A, Chatelain D, Lamotte L, Debuysscher V, Fuentes V, Nguyen-Khac E, Regimbeau JM, Marolleau JP, Latour S, Bouhlal H.

PLoS One. 2013 Dec 20;8(12):e82918. doi: 10.1371/journal.pone.0082918. eCollection 2013.

9.

Multi-faceted role of naturally occurring autoantibodies in fighting pathogens.

Bouhlal H, Kaveri S.

Adv Exp Med Biol. 2012;750:100-13. doi: 10.1007/978-1-4614-3461-0_8. Review.

PMID:
22903669
10.

Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide.

Carthagena L, Becquart P, Hocini H, Kazatchkine MD, Bouhlal H, Belec L.

Open Virol J. 2011;5:27-34. doi: 10.2174/1874357901105010027. Epub 2011 Apr 15.

11.

Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization.

Jenabian MA, Saïdi H, Charpentier C, Bouhlal H, Schols D, Balzarini J, Bell TW, Vanham G, Bélec L.

AIDS Res Ther. 2010 Jun 14;7:16. doi: 10.1186/1742-6405-7-16.

12.

Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.

Mayaud P, Legoff J, Weiss HA, Grésenguet G, Nzambi K, Bouhlal H, Frost E, Pépin J, Malkin JE, Hayes RJ, Mabey DC, Bélec L; ANRS 1212 Study Group.

J Infect Dis. 2009 Jul 15;200(2):216-26. doi: 10.1086/599991.

PMID:
19530940
13.

STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma.

Coppo P, Gouilleux-Gruart V, Huang Y, Bouhlal H, Bouamar H, Bouchet S, Perrot C, Vieillard V, Dartigues P, Gaulard P, Agbalika F, Douay L, Lassoued K, Gorin NC.

Leukemia. 2009 Sep;23(9):1667-78. doi: 10.1038/leu.2009.91. Epub 2009 May 7.

14.

Apical interactions of HIV type 1 with polarized HEC-1 cell monolayer modulate R5-HIV type 1 spread by submucosal macrophages.

Saïdi H, Magri G, Carbonneil C, Bouhlal H, Hocini H, Belec L.

AIDS Res Hum Retroviruses. 2009 May;25(5):497-509. doi: 10.1089/aid.2008.0156.

PMID:
19397398
15.

Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions.

Eslahpazir J, Jenabian MA, Bouhlal H, Hocini H, Carbonneil C, Grésenguet G, Mbopi Kéou FX, LeGoff J, Saïdi H, Requena M, Nasreddine N, de Dieu Longo J, Kaveri SV, Bélec L.

Clin Vaccine Immunol. 2008 May;15(5):872-84. doi: 10.1128/CVI.00463-07. Epub 2008 Mar 19.

16.

Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins.

Requena M, Bouhlal H, Nasreddine N, Saidi H, Gody JC, Aubry S, Grésenguet G, Kazatchkine MD, Sekaly RP, Bélec L, Hocini H.

Immunology. 2008 Apr;123(4):508-18. Epub 2007 Nov 10.

17.

Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells.

Chomont N, Hocini H, Gody JC, Bouhlal H, Becquart P, Krief-Bouillet C, Kazatchkine M, Bélec L.

Virology. 2008 Jan 20;370(2):246-54. Epub 2007 Oct 24.

18.

HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles.

Legoff J, Bouhlal H, Lecerf M, Klein C, Hocini H, Si-Mohamed A, Muggeridge M, Bélec L.

Virol J. 2007 Jan 5;4:2.

19.

Opsonization of HIV with complement enhances infection of dendritic cells and viral transfer to CD4 T cells in a CR3 and DC-SIGN-dependent manner.

Bouhlal H, Chomont N, Réquena M, Nasreddine N, Saidi H, Legoff J, Kazatchkine MD, Bélec L, Hocini H.

J Immunol. 2007 Jan 15;178(2):1086-95.

20.

Early archives of genetically-restricted proviral DNA in the female genital tract after heterosexual transmission of HIV-1.

Chomont N, Hocini H, Grésenguet G, Brochier C, Bouhlal H, Andréoletti L, Becquart P, Charpentier C, de Dieu Longo J, Si-Mohamed A, Kazatchkine MD, Bélec L.

AIDS. 2007 Jan 11;21(2):153-62.

PMID:
17197805
21.

Influence of storage temperature on the stability of HIV-1 RNA and HSV-2 DNA in cervicovaginal secretions collected by vaginal washing.

Legoff J, Tanton C, Lecerf M, Grésenguet G, Nzambi K, Bouhlal H, Weiss H, Belec L; ANRS1212 Study Group.

J Virol Methods. 2006 Dec;138(1-2):196-200. Epub 2006 Aug 21.

PMID:
16919788
22.

Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.

Legoff J, Bouhlal H, Grésenguet G, Weiss H, Khonde N, Hocini H, Désiré N, Si-Mohamed A, de Dieu Longo J, Chemin C, Frost E, Pépin J, Malkin JE, Mayaud P, Bélec L.

J Clin Microbiol. 2006 Feb;44(2):423-32.

23.

Natural antibodies to CCR5 from breast milk block infection of macrophages and dendritic cells with primary R5-tropic HIV-1.

Bouhlal H, Latry V, Requena M, Aubry S, Kaveri SV, Kazatchkine MD, Belec L, Hocini H.

J Immunol. 2005 Jun 1;174(11):7202-9.

24.
25.

Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells.

Bouhlal H, Chomont N, Haeffner-Cavaillon N, Kazatchkine MD, Belec L, Hocini H.

J Immunol. 2002 Sep 15;169(6):3301-6.

26.

Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1.

Bouhlal H, Hocini H, Quillent-Grégoire C, Donkova V, Rose S, Amara A, Longhi R, Haeffner-Cavaillon N, Beretta A, Kaveri SV, Kazatchkine MD.

J Immunol. 2001 Jun 15;166(12):7606-11.

27.

Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells.

Hocini H, Becquart P, Bouhlal H, Chomont N, Ancuta P, Kazatchkine MD, Bélec L.

J Virol. 2001 Jun;75(11):5370-4.

28.

Soluble CD16 inhibits CR3 (CD11b/CD18)-mediated infection of monocytes/macrophages by opsonized primary R5 HIV-1.

Bouhlal H, Galon J, Kazatchkine MD, Fridman WH, Sautès-Fridman C, Haeffner Cavaillon N.

J Immunol. 2001 Mar 1;166(5):3377-83.

30.

Restoration of normal interleukin-2 production by CD4+ T cells of human immunodeficiency virus-infected patients after 9 months of highly active antiretroviral therapy.

Weiss L, Ancuta P, Girard PM, Bouhlal H, Roux A, Cavaillon NH, Kazatchkine MD.

J Infect Dis. 1999 Oct;180(4):1057-63.

PMID:
10479131
31.

Involvement of the HIV-1 external envelope glycoprotein 120 (gp120) C2 region in gp120 oligomerization.

Seddiki N, Bouhlal H, Rabehi L, Benjouad A, Devaux C, Gluckman JC, Gattegno L.

Biochim Biophys Acta. 1997 Jul 18;1340(2):277-82.

PMID:
9252114

Supplemental Content

Loading ...
Support Center